Hints and tips:
...Recent examples include GI Partners joining Allscripts Healthcare Solutions to buy Netsmart Technologies, the healthcare software and services provider....
...Brothers and worked on transactions including Heineken and Carlsberg’s $20.2bn break-up bid for Scottish & Newcastle, Coca-Cola Hellenic’s relisting, and Misys’ $1.3bn disposal of its listed subsidiary Allscripts...
...Pre-tax profit fell 28 per cent to £32.2m as Misys faced a number of exceptional charges and fees related to the acquisition of Sophis and the disposal of Allscripts, the company’s healthcare software business...
...Several established health companies, including Athenahealth and Allscripts, offer doctors a data server and software system to meet the requirement. Typical cost ranges from $44,000 to $64,000....
...A deal would follow the $1.3bn sale of Misys’s Allscripts healthcare business last year, and complete a five-year turnround of the business by Mike Lawrie, chief executive....
...His strategy of simplifying Misys by shedding its stake in Allscripts and focusing on banking, treasury and capital markets is starting to pay off....
...Misys, the financial software provider, is poised to acquire Irish rival Sophis for £235m with funds from the disposal of Allscripts, its healthcare arm....
...Last week Misys, the financial software provider, said it would acquire rival Sophis for £235m with funds from the disposal of its Allscripts healthcare arm....
...The merger of Allscripts and Misys was central to the UK company’s turnround....
...The sale of Misys’s majority stake in Allscripts is a fabulous return for two years’ work, according to the FT....
...By any calculation, the sale of Misys’s majority stake in Allscripts is a fabulous return for two years’ work....
...Precisely how good the latest deal is, depends on the price at which Misys places its Allscripts shares and the consummation of Allscripts’ merger with Eclipsys, another IT company....
...Related link: Misys moves to sell Allscripts stake – FT...
...It will retain a stake of about 8 to 10 per cent in the combined Allscripts-Eclipsys business....
...The precise outcome of the complex deal depends on various imponderables – including the price at which Misys places its shares in Allscripts and the consummation of Allscripts’ merger with Eclipsys, another...
...Allscripts was 9.7 per cent lower at $16.64....
...Misys owns 57 per cent of Allscripts, the US healthcare software company, and is expected to be a big beneficiary of the stimulus package, part of which is earmarked for helping doctors to modernise their...
...Among the mid-caps, Misys added 3.7 per cent to 266p after its Allscripts subsidiary pushed ahead with a share issue as part of the sale of the division to Eclipsys....
...Earnings per share fell from 14.7p to 4.0p to reflect the shares issued to help fund the purchase of Allscripts, its US healthcare software division....
...Misys led the mid-cap risers, up 11.4 per cent to 249p on news that it would sell most of its stake in its Allscripts subsidiary for more than $1bn, which will be returned to shareholders via a tender offer...
...Allscripts trades on Nasdaq at about 28 times earnings expectations....
...Allscripts, its Nasdaq-listed healthcare division, has risen by almost 17 per cent this month while Misys had gained just 3.3 per cent before Monday....
...A month ago Misys refinanced the debt package it had agreed to secure the acquisition of Allscripts....
...While Allscripts performed ahead of expectations, the financial crisis delayed orders at Misys’s treasury and capital markets business....
...Mike Lawrie, chief executive, has made Allscripts-Misys central to his planned three- to five-year turnround, begun in 2006....
International Edition